Shutterstock.com / Alamy Stock Photo
Our research briefings are concise and informative, designed to keep readers up to date with the latest developments in science and clinical research — from novel uses for existing drugs to studies assessing potential new treatments.
In 2019, our most popular research briefings have spanned a variety of subjects and treatment areas relevant to pharmacists, from the debated benefits of vitamin D supplementation to medical uses of cannabinoids, and the repurposing of statins and metformin as treatments for mental health conditions.
Recap on the science and clinical research that has emerged in 2019 with our top ten most-read research briefings below, and rediscover articles that are still popular from 2018.
10. Sertraline may reduce anxiety more quickly than depressive symptoms
9. Potential interaction between diuretics and laxatives found
8. Vitamin D supplementation boosts insulin sensitivity
7. First-line immunotherapy does not improve survival in metastatic lung cancer
6. Tramadol and methadone users are at increased risk of hypoglycaemia, study reveals
5. Cannabinoids could help manage spasticity in motor neurone disease
4. Researchers find strong link between vitamin D deficiency and diabetes-related deaths
3. Long-term follow-up allays fears that finasteride increases mortality
2. Statins and metformin could be used to treat serious mental illness
1. Enzyme mouth spray could shorten cold duration
Still popular from 2018
5. Durvalumab increases overall survival in stage III non-small-cell lung cancer
4. Researchers find that e-cigarette fluid becomes more toxic during vaping
3. Daily vaping increases heart attack risk
2. New antibiotic effective against multi-drug resistant Gram-negative UTI
1. HPV infection increases risk of reinfection, study finds
